BioCentury | Feb 8, 2010
Finance

Regulatory milestones

...million ($40 million) in funding from MVM Life Science Partners, Forbion Capital Partners, Encore Ventures, TTP Venture Fund...
BioCentury | Feb 8, 2010
Company News

Argenta Discovery, Galapagos deal

...Pulmagen Therapeutics Ltd. Pulmagen investors include MVM Life Science Partners, Forbion Capital Partners, Encore Ventures, TTP Venture Fund...
Items per page:
1 - 2 of 2
BioCentury | Feb 8, 2010
Finance

Regulatory milestones

...million ($40 million) in funding from MVM Life Science Partners, Forbion Capital Partners, Encore Ventures, TTP Venture Fund...
BioCentury | Feb 8, 2010
Company News

Argenta Discovery, Galapagos deal

...Pulmagen Therapeutics Ltd. Pulmagen investors include MVM Life Science Partners, Forbion Capital Partners, Encore Ventures, TTP Venture Fund...
Items per page:
1 - 2 of 2